Psychedelic Stocks Soar as Trump Signs Order to Ease Access
Shares of companies involved in psychedelic-related therapies are surging in premarket trading Monday after President Donald Trump signed an executive order to expedite research and access.
Trump's psychedelics executive order
- Compass Pathways CEO on Trump's Order to Expand Psychedelics Research Bloomberg —
- FDA's Makary on Trump EO to Ease Access to Psychedelics Bloomberg —
- Trump’s order on psychedelics could have far-reaching science consequences Scientific American —
- How Trump's psychedelics executive order could unlock stalled cannabis reform CNBC —
- Trump administration moves forward with certain drug reclassifications CBS News —